
Emerging SME Services · BSE
Astonea Labs Ltd., established in 2017, is engaged in the contract manufacturing of pharmaceutical and cosmetic products for both Indian and international companies. The company produces a wide range of medicines, including antibiotics and treatments for colds, infections, diabetes, heart conditions, and gynecological issues. It also manufactures skincare, haircare, and dental care products in the form of gels, creams, and serums. In addition to manufacturing, Astonea Labs provides packaging and raw materials to other pharmaceutical and cosmetic companies, adhering to industry standards. The company markets its own brands—Glow Up, a dermo-cosmetic line, and Regero, a pharmaceutical range—and is preparing to launch a new brand named Avicel. It also exports products to countries like Iraq and Yemen. As of August 16, 2024, the company had 217 employees on its payroll.
Price Band
₹128 – ₹135
Issue Size
₹37.67 Cr
Lot Size
1000 shares
GMP
Est. Listing
₹135
at current GMP
Subscribed
2.55x
overall
Open
27 May 2025
Close
29 May 2025
Allotment
30 May 2025
Refund
31 May 2025
Demat Credit
1 Jun 2025
Listing
3 Jun 2025
Overall Subscription
2.55x
Total Demand
QIB Multiplier
1.75x
Institutions & Funds
NII / HNI
5.60x
High Net-Worth
Retail (RII)
1.69x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 530,000 | 927,000 | 1.75x |
| NIB | 399,000 | 2,233,000 | 5.60x |
| RETAIL | 927,000 | 1,567,000 | 1.69x |
| Total | 1,856,000 | 4,727,000 | 2.55x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 977 | 1,651 | 1.69x |
| HNIs (10L +) | 6 | 34 | 5.60x |
| HNIs (2-10L) | 30 | 168 | 5.60x |
| Total Applications | 1,013 | 1,853 | 1.83x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Astonea Labs Limited is bringing an initial public offering (IPO) in the Emerging SME Services sector with an aggregate issue size of ₹37.67 Crores. The shares are offered at a price band of ₹128 to ₹135 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,35,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-06-01, while un-allotted funds or UPI block mandates will be released on 2025-05-31.
Currently, Astonea Labs Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹128 to ₹135 per equity share.
The retail lot size is 1000 shares requiring a minimum application amount of ₹1,35,000. Expected listing price is ₹135 per equity share.
The Astonea Labs Limited IPO aggregate issue size is ₹37.67 Crores with an equity price band set at ₹128 to ₹135 per equity share. The retail lot size is 1000 shares requiring a minimum capital outlay of approx. ₹1,35,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 2.55x (Retail: 1.69x, QIB: 1.75x, NII: 5.60x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2025-05-30. Investors can verify status using PAN card or application number.
Astonea Labs Limited shares are scheduled to list on BSE on 2025-06-03.